Skip to content Skip to sidebar Skip to footer

Windlas Biotech Ipo : Y0wuyn6ovx8km - Earnings per share (eps) = rs 8.70 pe ratio = na.

Windlas Biotech Ipo : Y0wuyn6ovx8km - Earnings per share (eps) = rs 8.70 pe ratio = na.. Windlas biotech limited is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (cdmo) industry in india in terms of revenue. In 2001, windlas biotech limited (after this referred to as 'the company') got incorporated in delhi. Link intime india private ltd is the registrar for the ipo. The offer will be available till friday, august 6, 2021. Subsequently, the company was converted to a private limited company in 2016 and returned to a public limited company in early.

The windlas biotech ipo lot size is 30 shares and the minimum order quantity is 30 shares. We share the gmp information for educational purposes only, so that, you can make an informed decision. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Incorporated in 2001, windlas biotech ltd.

Am2snn5m7spcm
Am2snn5m7spcm from images.financialexpress.com
Subsequently, the company was converted to a private limited company in 2016 and returned to a public limited company in early. Face value = rs 5. The company offers a range of cdmo services from product discovery to product development, licensing, and commercial manufacturing. The company plans to raise rs 401.53 crore with the help of fresh issuance of equity. Windlas biotech limited, a leading manufacturer in pharmaceutical designs, launched its initial public offering (ipo) today (4 august). The company to raise ₹165 crores via fresh issue and the offer for sale will be 5,142,067 shares as per drhp, the face value of the windlas biotech share is ₹5. The minimum order quantity is 30 shares. Is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organisations segment in india.

Meanwhile, the price band for the ipo stood at rs 448 to rs 460 per equity share, while the grey market premium.

Windlas biotech limited ipo will open on 04 aug 2021 and close on 06 aug 2021. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. Windlas biotech, an indian drugmaker, is set to open for initial public offering on august 4, with a fresh issue of rs 165 crore and an offer for sale of 51.42 lakh equity shares by existing shareholders. Windlas biotech ipo will hit the market in 2021. The windlas biotech ipo price band at rs.448 to rs.460 per share. Windlas biotech is planning to raise ₹401.54 crores through an ipo which consists of a fresh issue of ₹165 crores worth equity and ofs (offer for sale) of ₹236.54 by existing shareholders. Grey market premium (gmp) today: Incorporated in 2001, windlas biotech ltd. The face value of this ipo is ₹5 per equity share. The company was incorporated in 2001. What is the lot size for windlas biotech limited's ipo? The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organisations segment in india.

This ipo will be open for subscriptions for three consecutive days and it will close on 6 august. In 2001, windlas biotech limited (after this referred to as 'the company') got incorporated in delhi. Siddharth a july 29, 2021. The company offers a range of cdmo services from product discovery to product development, licensing, and commercial manufacturing. May 15, 2021 by profitmust.

Gb Dolxab4b5rm
Gb Dolxab4b5rm from images.hindustantimes.com
Windlas biotech's ipo was subscribed 1.20 times, with the retail individual investors category receiving 2.36 times subscription. Meanwhile, the price band for the ipo stood at rs 448 to rs 460 per equity share, while the grey market premium. Face value = rs 5. Siddharth a july 29, 2021. What is the listing date of windlas biotech limited ipo? The ipo received bids for 73,89,420 shares against 61,36,252. The issue size of windlass ipo is ₹401.54 crore. Demat account, trading application and upi id are mandatory if you are applying for an initial public offering (ipo).

The registrar is link intime india private limited.

The minimum order quantity is 30 shares. May 15, 2021 by profitmust. The face value of this ipo is ₹5 per equity share. We share the gmp information for educational purposes only, so that, you can make an informed decision. What is the lot size for windlas biotech limited's ipo? Demat account, trading application and upi id are mandatory if you are applying for an initial public offering (ipo). Subsequently, the company was converted to a private limited company in 2016 and returned to a public limited company in early. Analysts at marwadi shares, angel broking, gepl capital and bp wealth also suggest subscribing to the issue. What is the size of the issuance. Any anchor bookings that might take place would happen on august 3, before the opening day. Windlas biotech limited ipo will open on 04 aug 2021 and close on 06 aug 2021. The company was incorporated in 2001. Link intime india private ltd is the registrar for the ipo.

However, the head office shifted to uttarakhand in 2009 under shareholders approval. What is the size of the issuance. Windlas biotech ipo is an ipo of windlas biotech limited which is one of the top 5 companies in pharmaceutical formulation contract development and manufacturing organization (cdmo) segment in india. Windlas biotech, an indian drugmaker, is set to open for initial public offering on august 4, with a fresh issue of rs 165 crore and an offer for sale of 51.42 lakh equity shares by existing shareholders. Link intime india private ltd is the registrar for the ipo.

Windlas Biotech Ipo Dates Review Price Form Lot Size Allotment Details 2021
Windlas Biotech Ipo Dates Review Price Form Lot Size Allotment Details 2021 from ipobazar.in
Windlas biotech limited ipo will list on 17 aug 2021. The bidding will close on august 6. The minimum order quantity is 30 shares. Who is the registrar for windlas biotech ipo ? The windlas biotech ipo lot size is 30 shares and the minimum order quantity is 30 shares. However, the head office shifted to uttarakhand in 2009 under shareholders approval. The company offers a range of cdmo services from product discovery to product development, licensing, and commercial manufacturing. The issue is priced at ₹448 to ₹460 per equity share.

The windlas biotech ipo price band at rs.448 to rs.460 per share.

Demat account, trading application and upi id are mandatory if you are applying for an initial public offering (ipo). Windlas biotech limited ipo will open on 04 aug 2021 and close on 06 aug 2021. The initial public offer of equity shares comprising a fresh issue of up to rs.401 crore. Face value = rs 5. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The ipo opens on aug 4, 2021, and closes on aug 6, 2021. The issue is priced at ₹448 to ₹460 per equity share. Who is the registrar for windlas biotech ipo ? The price band is set at rs 448 to rs 460 per equity share. The grey market is an unofficial platform, wherein trading starts after the announcement of ipo price band till the listing of. The ipo received bids for 73,89,420 shares against 61,36,252. The ipo received bids for 1,93,37,310 shares against 61,36,252 shares on offer, as per data with the nse. The minimum order quantity is 30 shares.